peptide linkerlass as a glutamate theranostics (spect 99m Tc PET 18 Fand pet) for neurodegenrative disorder
peptide linkerlass as a glutamate theranostics (spect 99m Tc PET 18 Fand pet) for neurodegenrative disorder
Created using ChatSlide
This presentation explores the critical role of glutamate theranostics in addressing unmet needs in neurodegeneration. It highlights glutamate's significance as a primary excitatory neurotransmitter and its involvement in conditions like Alzheimer's and Parkinson's diseases. The theranostic approach aims to integrate diagnostic imaging with targeted treatment, enhancing patient-specific decision-making. Key topics include peptide linker design for optimal brain exposure, the advantages of...